Download presentation
Published byAlexander Atkinson Modified over 11 years ago
1
The Diagnostic Evaluation and Treatment of Recurrent Pregnancy Loss
Ashim Kumar, M.D. Reproductive Endocrinology and Infertility Clinical Assistant Professor, UCLA School of Medicine Fertility & Surgical Associates of California, Encino & Thousand Oaks, CA
2
Luteal Support Progesterone +/- Estradiol
Start after ovulation or egg retrieval Continue until 10 weeks gestational age
3
Early Pregnancy Reassurance Ultrasounds Pelvic rest as needed
As Indicated Monitor TSH Monitor BP
4
Prenatal Testing Screening Diagnostic
1st Trimester – Nuchal Fold + Serum 2nd Trimester – Triple/Quadruple Screen Diagnostic 1st Trimester – Chorionic Villus Sampling 2nd Trimester – Amniocentesis
5
Recurrent Pregnancy Loss
SAB: involuntary loss of pregnancy before 20wk GA RPL: Three or more pregnancy losses in the first trimester Indications to evaluate after 2 or more consecutive losses: + FCA in prior loss Normal Karyotype on prior loss Female > 35yr Infertility Emotional Support is critical
6
Risk of RPL in Young Women
# of Prior SAB’s % Risk of SAB in Next Pregnancy h/o prior liveborn 12% 1 24% 2 26% 3 32% 4 6 53% No liveborn 2 or more 40-45%
7
Early Pregnancy Loss Clinically unrecognized (less than 8wk GA)
30-60% of all pregnancies end in SAB At least ½ are early losses (go unnoticed) ~75% of embryos with chromosomal abnormalities 90% are numerical (aneuploidy/polyploidy) Rest are structural or mosaicism 2/3 of the remaining 25% with normal karyotype exhibit gross structural abnormalities
8
Etiology Uterine Defect (~30%) Thrombophilia Genetic General Endocrine
Congenital Acquired Thrombophilia Immunologic (~3-5%) Genetic Meiotic Nondisjunction Balanced Translocation (5%) General Endocrine
9
Uterine Defect Congenital Acquired Septum Bicornuate / Unicornuate
T-Shaped Uterus Acquired Submucosal Leiomyoma Endometrial Polyp Synechia Adenomyosis
10
Uterine Evaluation Ultrasound Sonohysterogram (saline ultrasound)
Hysterosalpingogram MRI Hysteroscopy
11
Bicornuate or Septate
12
Endometrial Polyp
13
Thrombophilias Congenital Immunologic - Antiphospholipid Syndrome
Factor V Leiden Mutation Protein C / Protein S Deficiency Prothrombin Gene Mutation Methylenetetrahydrofolate Reductase (MTHFR) – homocysteine Antithrombin III Immunologic - Antiphospholipid Syndrome Anticardiolipin Antibodies Lupus Anticoagulant
14
Virchow’s Triad Stasis (Decrease flow in placental vessels)
Damaged Vasculature Hypercoagulable State Cancer Pregnancy (Elevated Estradiol leads to increased hepatic production of clotting factors) Congenital Immunologic
15
Genetic Meiotic Nondisjunction Balanced Translocation (5% of couples)
Risk of miscarriage increases with advancing reproductive age Balanced Translocation (5% of couples) Robertsonian Reciprocal Others Mosaicism Inversion Chromosomally abnormal sperm do not play a role in RPL
16
Meiotic Nondisjunction
17
Age and Miscarriage Risk
<30 yr % 30-34 yr- 8-21% 35-39 yr % ≥40 yr %
18
Risk of Chromosomal Abnormality in Newborns by Maternal Age
Maternal Fetal Medicine: Practice and Principles. Creasey and Resnick 1994
19
Preimplantation Genetic Diagnosis
20
Preimplantation Genetic Diagnosis
21
Preimplantation Genetic Diagnosis
22
Robertsonian Translocation
23
Reciprocal Translocation
24
General Endocrine Diabetes (Fasting Glucose) Thyroid Disease (TSH)
Hyperprolactinemia (Prolactin) Polycystic Ovary Syndrome Luteal Phase Deficiency (Supplement Everyone)
25
Treatment Provide Emotional Support Uterus Hypercoagulable State
Resect lesion Hypercoagulable State Heparin Aspirin Folate Genetic PGD General Endocrine Correct hormonal imbalance
26
What Does Not Work Alloimmune Disorders Genetic Hypercoagulable State
Testing HLA testing Mixed lymphocyte culture Natural killer cell assay Treatment Paternal leukocyte immunization Intravenous immunoglobulins (IVIG) Genetic PGD Hypercoagulable State Glucocorticoids Uterus Metroplasty
27
Conclusion The likelihood of successful delivery is very high. The challenge is to do it an a cost-effective fashion while being sensitive to the emotional sequelae.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.